Fairmount Funds Management LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
Fairmount Funds Management LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2022$13,408,0002,245,8913.07%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders